AbbVievsPro-Dex

ABBV and PDEX stock compared: price, dividend, valuation and results, from SEC filings.

PDEX

Pro-Dex, Inc.

$65.66

Value $210M

-2.61%
PDEX's page

AbbVie (ABBV) has a market value of $522B and Pro-Dex (PDEX) $210M. Over the last year, with dividends, ABBV moved +30.3% and PDEX +102.2%. The P/E is 50.7 for ABBV and 17.5 for PDEX. Dividend yield: ABBV 2.35%, PDEX none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$522B

    PDEX$210M

    ABBV is 2,480 times PDEX

  • Revenue, 12 months

    ABBV$66.0B

    PDEX$80M

    ABBV is 830 times PDEX

  • Net income, 12 months

    ABBV$10.3B

    PDEX$12M

    ABBV is 860 times PDEX

  • Operating margin

    ABBV32.2%

    PDEX16.8%

    15.4 points apart

  • ROIC

    ABBV25.7%

    PDEX17.4%

    8.3 points apart

  • P/E

    ABBV50.7

    PDEX17.5

    ABBV is 2.9 times PDEX

  • Dividend yield

    ABBV2.4%

    PDEX0.0%

    2.4 points apart

  • 5-year return

    ABBV+201.5%

    PDEX+182.3%

    19.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABBV+201.5%

PDEX+182.3%

10020030020222023202420252026
Returns by period
PeriodABBVWith dividendsPDEXWith dividends
1 year since November 12, 2025+30.3%Price +26.5%+102.2%Price +102.2%
3 years since November 13, 2023+135.3%+33.0% a yearPrice +112.8%+266.6%+54.2% a yearPrice +266.6%
5 years since November 12, 2021+201.5%+24.7% a yearPrice +152.2%+182.3%+23.1% a yearPrice +182.3%
10 years since November 15, 2016+605.5%+21.6% a yearPrice +369.3%+1,343.1%+30.6% a yearPrice +1,343.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbViePDEXPro-Dex

Valuation

ABBVPDEX
Valuation
Price$295.03$65.66
Market value$522B$210M
Enterprise value (EV)$592B$214M
P/E50.717.5
P/E, 5-year median57.014.2
P/B–4.3
EV/EBIT27.916.0
Free cash flow yield3.6%5.1%

Results and growth

ABBVPDEX
Results and growth
Revenue, 12 months$66.0B$80M
Net income, 12 months$10.3B$12M
Free cash flow, 12 months$18.9B$11M
Earnings per share, 12 months$5.81$3.63
Revenue growth, year on year8.6%16.5%
Revenue growth a year, past+5.9%over 5 years+15.3%over 5 years
EPS growth a year, past-2.8%over 5 years+21.3%over 5 years

Margins and returns on capital

ABBVPDEX
Margins and returns on capital
Gross margin73.7%32.5%
Operating margin32.2%16.8%
Net margin15.7%15.1%
ROIC25.7%17.4%
ROE–26.7%

Balance sheet

ABBVPDEX
Balance sheet
Cash$10.8B$13M
Total debt$80.9B$19M
Net debt / EBITDA3.20.2
Interest cover7.1×15.4×

Dividends and buybacks

ABBVPDEX
Dividends and buybacks
Dividend yield2.4%–
Dividend per share, 12 months$6.92–
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%1.6%
Shareholder yield2.5%1.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or PDEX

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or Pro-Dex?

By market value, AbbVie ($522B) is about 2,480.2 times Pro-Dex ($210M), at today's prices.

How did ABBV and PDEX stock do over the last 10 years?

Since November 15, 2016, ABBV's price moved +369.3% and PDEX's +1,343.1%. With dividends: ABBV +605.5% (+21.6% a year), PDEX +1,343.1% (+30.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABBV or PDEX?

The dividend yield at today's price is 2.35% for AbbVie and none for Pro-Dex. Over the last twelve months they paid $6.92 and – per share.

What is the P/E of ABBV and PDEX?

At today's price, the P/E is 50.7 for ABBV and 17.5 for PDEX. The median of the last five years was 57.0 and 14.2, which shows where each stands against its own past.

Which has the higher profit margins, AbbVie or Pro-Dex?

Over the last twelve months, the net margin was 15.7% for AbbVie and 15.1% for Pro-Dex, and the operating margin 32.2% and 16.8%. Revenue was $66.0B and $80M.

Which is the better investment, AbbVie or Pro-Dex?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.